Cargando…

Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute

The average time required for cancers to progress through stages can be reflected in the average age of the patients diagnosed at each stage of disease. To estimate the time it takes for non-small-cell lung cancer (NSCLC) to progress through different tumor, node and metastasis (TNM) stages and size...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Ping, Cao, Jin Lin, Rustam, Azmat, Zhang, Chong, Yuan, Xiao Shuai, Bao, Fei Chao, Lv, Wang, Hu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921917/ https://www.ncbi.nlm.nih.gov/pubmed/27346236 http://dx.doi.org/10.1038/srep28477

Ejemplares similares

Treatment Patterns for Patients With Unresected Stage III NSCLC: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
por: Shang, Shijie, et al.
Publicado: (2022)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

Discordance of pathological thin melanoma thickness and T stage in SEER registry: impacts on clinical management and research directions
por: Wang, Zhichao, et al.
Publicado: (2017)

Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept
por: Berghmans, Thierry, et al.
Publicado: (2020)

Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries
por: Tai, Patricia, et al.
Publicado: (2004)

Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER database
por: Wang, Xia, et al.
Publicado: (2021)

Development and validation of a nomogram for predicting survival time and making treatment decisions for clinical stage IA NSCLC based on the SEER database
por: Xu, Bingchen, et al.
Publicado: (2022)

Head & neck acinar cell carcinoma: a population-based study using the seer registry
por: Yibulayin, Feiluore, et al.
Publicado: (2020)

Identification of Resectable N2 in NSCLC: A Single Center Experience and Review of the SEER Database
por: Wang, Yan-qing, et al.
Publicado: (2021)

Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014
por: Pan, Yue, et al.
Publicado: (2018)

Fine Particulate Matter Exposure and Cancer Incidence: Analysis of SEER Cancer Registry Data from 1992–2016
por: Coleman, Nathan C., et al.
Publicado: (2020)

Risk of Alzheimer’s Disease in Cancer Patients: Analysis of Mortality Data from the US SEER Population-Based Registries
por: Mezencev, Roman, et al.
Publicado: (2020)

Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis
por: Guo, Meiying, et al.
Publicado: (2019)

Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry
por: Brat, Kristian, et al.
Publicado: (2020)

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries
por: Berrington de Gonzalez, A, et al.
Publicado: (2010)

Factors associated with late risks of breast cancer-specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

Sinonasal Mucosal Melanoma: A Population-based Comparison of the EUROCARE and SEER Registries
por: Temmermand, David, et al.
Publicado: (2022)

High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
por: Piper-Vallillo, A.J., et al.
Publicado: (2022)

Long-term survival outcomes of pediatric adrenal malignancies: An analysis with the upstaged SEER registry during 2000-2019
por: Lv, Zemin, et al.
Publicado: (2022)

Survival comparison of stage IIA rectal cancer with or without neoadjuvant therapy: a SEER database analysis with propensity score matching
por: Yan, Han, et al.
Publicado: (2022)

Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry
por: Mattes, Malcolm D., et al.
Publicado: (2015)

Early-onset pancreatic cancer: a population-based study using the SEER registry
por: Ansari, Daniel, et al.
Publicado: (2019)

Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021)

Subsite‐specific metastatic organotropism and risk in gastric cancer: A population‐based cohort study of the US SEER database and a Chinese single‐institutional registry
por: Wang, Ling, et al.
Publicado: (2023)

Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases
por: Zheng, Mei-Mei, et al.
Publicado: (2022)

Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC()
por: Charkiewicz, Radoslaw, et al.
Publicado: (2017)

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
por: Liang, Wenhua, et al.
Publicado: (2017)

Survival Analysis and Prediction Model of ASCP Based on SEER Database
por: Lv, Sun-Yuan, et al.
Publicado: (2022)

Mortality from heart disease following radiotherapy in esophageal carcinoma: a retrospective cohort study in US SEER cancer registry
por: Zhai, Huamin, et al.
Publicado: (2020)

TdIF1: a putative oncogene in NSCLC tumor progression
por: Zhang, Yujuan, et al.
Publicado: (2018)

Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation
por: Zhang, Nannan, et al.
Publicado: (2020)

Use of Mastectomy for Overdiagnosed Breast Cancer in the United States: Analysis of the SEER 9 Cancer Registries
por: Harding, C., et al.
Publicado: (2019)

Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis
por: Jani, Krupa S., et al.
Publicado: (2021)

Impact on the Volume of Pathology Reports Before and During the COVID-19 Pandemic in SEER Cancer Registries
por: Chtourou, Amina, et al.
Publicado: (2023)

Gastrectomy for stage IV gastric cancer: a comparison of different treatment strategies from the SEER database
por: Desiderio, Jacopo, et al.
Publicado: (2021)

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Lv, Hao, et al.
Publicado: (2021)

Numbers and Stations: Impact of Examined Lymph Node on Precise Staging and Survival of Radiologically Pure-Solid NSCLC: A Multi-Institutional Study
por: Chen, Donglai, et al.
Publicado: (2020)

SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients
por: Emprou, Camille, et al.
Publicado: (2018)

Surgery in Masaoka stage IV thymic carcinoma: a propensity-matched study based on the SEER database
por: Ye, Cong, et al.
Publicado: (2020)

Histological and Demographic Characteristics of the Distribution of Brain and Central Nervous System Tumors’ Sizes: Results from SEER Registries Using Statistical Methods
por: Pokhrel, Keshav P., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vdqjgts6gdcpncmhduteefl5p1